Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Advances in gout: some answers, more questions.

Singh JA.

Arthritis Res Ther. 2010;12(5):136. doi: 10.1186/ar3110. Epub 2010 Sep 24.

2.

Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.

Stevenson M, Pandor A.

Health Technol Assess. 2009 Oct;13 Suppl 3:37-42. doi: 10.3310/hta13suppl3/06. Review.

3.

Febuxostat: a new treatment for hyperuricaemia in gout.

Edwards NL.

Rheumatology (Oxford). 2009 May;48 Suppl 2:ii15-ii19. doi: 10.1093/rheumatology/kep088. Review.

PMID:
19447778
4.

A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout.

Faruque LI, Ehteshami-Afshar A, Wiebe N, Tjosvold L, Homik J, Tonelli M.

Semin Arthritis Rheum. 2013 Dec;43(3):367-75. doi: 10.1016/j.semarthrit.2013.05.004. Review.

PMID:
24326033
5.

Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis.

Ye P, Yang S, Zhang W, Lv Q, Cheng Q, Mei M, Luo T, Liu L, Chen S, Li Q.

Clin Ther. 2013 Feb;35(2):180-9. doi: 10.1016/j.clinthera.2012.12.011. Epub 2013 Jan 16. Review.

PMID:
23332451
6.

Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal.

Stevenson M, Pandor A.

Pharmacoeconomics. 2011 Feb;29(2):133-40. doi: 10.2165/11535770-000000000-00000. Review.

PMID:
21155617
7.

Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.

Ernst ME, Fravel MA.

Clin Ther. 2009 Nov;31(11):2503-18. doi: 10.1016/j.clinthera.2009.11.033. Review.

PMID:
20109996
8.

Febuxostat for treatment of chronic gout.

Gray CL, Walters-Smith NE.

Am J Health Syst Pharm. 2011 Mar 1;68(5):389-98. doi: 10.2146/ajhp100394. Review.

PMID:
21330679
9.

Febuxostat.

Hair PI, McCormack PL, Keating GM.

Drugs. 2008;68(13):1865-74. Review.

PMID:
18729537
10.

Urate-lowering therapy for gout: focus on febuxostat.

Love BL, Barrons R, Veverka A, Snider KM.

Pharmacotherapy. 2010 Jun;30(6):594-608. doi: 10.1592/phco.30.6.594. Review.

PMID:
20500048
11.

Febuxostat (Uloric) for chronic treatment of gout.

[No authors listed]

Med Lett Drugs Ther. 2009 May 18;51(1312):37-8. Review.

PMID:
19448587
12.

Febuxostat for the treatment of gout.

Bridgeman MB, Chavez B.

Expert Opin Pharmacother. 2015 Feb;16(3):395-8. doi: 10.1517/14656566.2015.985588. Epub 2015 Jan 5. Review.

PMID:
25556668
13.

Uricase and other novel agents for the management of patients with treatment-failure gout.

Sundy JS, Hershfield MS.

Curr Rheumatol Rep. 2007 Jun;9(3):258-64. Review.

PMID:
17531181
14.

Progress in the pharmacotherapy of gout.

Sundy JS.

Curr Opin Rheumatol. 2010 Mar;22(2):188-93. doi: 10.1097/BOR.0b013e3283369014. Review.

PMID:
20110792
15.

[Febuxostat].

Wittköpper K, Emons J, El-Armouche A.

Dtsch Med Wochenschr. 2011 Jun;136(23):1270-4. doi: 10.1055/s-0031-1272573. Epub 2011 May 23. Review. German. No abstract available.

PMID:
21607898
16.

Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis.

Castrejon I, Toledano E, Rosario MP, Loza E, Pérez-Ruiz F, Carmona L.

Rheumatol Int. 2015 Jul;35(7):1127-37. doi: 10.1007/s00296-014-3189-6. Epub 2014 Dec 18. Review. Erratum in: Rheumatol Int. 2015 Jul;35(7):1139.

PMID:
25519877
17.

Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis.

Borghi C, Perez-Ruiz F.

Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):983-92. Review.

18.

Febuxostat: a novel non-purine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in gout.

Yu KH.

Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):69-75. Review.

PMID:
19075968
19.

Update on emerging urate-lowering therapies.

Chohan S, Becker MA.

Curr Opin Rheumatol. 2009 Mar;21(2):143-9. doi: 10.1097/BOR.0b013e328325bd94. Review. Erratum in: Curr Opin Rheumatol. 2010 Jan;22(1):106.

PMID:
19339925
20.

Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.

Frampton JE.

Drugs. 2015 Mar;75(4):427-38. doi: 10.1007/s40265-015-0360-7. Review.

PMID:
25724536

Supplemental Content

Support Center